Our results are in accordance with the study by Brouwer et al. [16] where PAGE-B was the overall best performing risk score for all outcomes (both survival and HCC development) compared to REACH-B, FIB-4, AST to Platelet Ratio Index (APRI), and GAG-HCC and CU-HCC risk models, with a c-statistic of 0.91 (95% CI 0.82–0.99). This evidence concerns the gene GOT1 and hepatocellular carcinoma.